About this program

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support of the Coccidioidomycosis Collaborative Research Centers (CCRCs). The CCRCs are highly collaborative, multi-disciplinary, research centers that conduct clinical and translational research to support the development of a vaccine to combat coccidioidomycosis (Valley fever), a serious and difficult to treat fungal infection endemic in many regions of the United States. Activities to be supported align with the NIAID strategic plan for research to develop a Valley fever vaccine and include (1) addressing gaps in basic Coccidioides research, (2) development of tools and resources, and (3) development of a preventative vaccine. The expectation is that the multi-disciplinary centers will leverage unique research resources and patient populations from endemic regions to advance the field. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Eligibility

• Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized)
• Eligible Agencies of the Federal Government
• U.S. Territory or Possession
• Faith-based or Community-based Organizations
• Regional Organizations
• Non-domestic (non-U.S.) Entities (Foreign Institutions).

Contact & website